Executive Vice President, Operations · Boston Scientific Corp. (BSX)

Edward Mackey

A named executive officer of Boston Scientific in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$3,599,526

Salary $497,670Stock awards $2,144,740

FY2019: $3,198,962

4th of 5 named executive officers at Boston Scientific by FY2020 total.

5 named officers on file for Boston Scientific, FY2020

Edward Mackey’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 9 equity grants, each cited to its filing
  • BSX’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Boston Scientific’s whole pay program stands against its peers

  • Boston Scientific’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BSX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 24, 2021 (DEF 14A).

Free

Get Edward Mackey’s full pay file as a PDF — free

More than this page: up to 10 years of Edward’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Edward Mackey compensation by year

Boston Scientific Summary Compensation Table · all 2 fiscal years held
In US dollars, as Boston Scientific reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$577,398$497,670
Bonus$0$0
Stock awards$1,472,367$2,144,740
Option awards$437,491$374,991
Non-equity incentive$520,282$391,374
Pension and deferred compensation$156,573$170,059
All other$34,851$20,692
Total$3,198,962$3,599,526

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Boston Scientific Corp. DEF 14A filed March 24, 2021, accession 0001047469-21-000709, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Boston Scientific Corp. filed document, accession 0001047469-21-000709. Every figure is read from that document and cited to the page and table it appears in. Filed March 24, 2021.

$3.2M
$3.6M
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU23,719$852,698—
RSU16,318$586,632—
RSU10,796$388,116—
RSU9,824$353,173—
RSU8,894$319,739—
RSU8,306$298,601—
RSU8,178$293,999—
RSU7,880$283,286—
RSU4,888$175,724—
PSU4,361$156,778—
PSU3,557$127,874—
RSU2,897$104,147—

Per the Outstanding Equity Awards at Fiscal Year-End table in Boston Scientific Corp.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 16 award rows shown.

Boston Scientific’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Michael MahoneyChairman of the Board, President and Chief Executive Officer$13,773,795
Joseph FitzgeraldExecutive Vice President and President, Cardiology$4,598,333
Daniel BrennanExecutive Vice President and Chief Financial Officer$3,668,993
Edward Mackey · this pageExecutive Vice President, Operations$3,599,526
Jeffrey MirvissExecutive Vice President and President, Peripheral Interventions$2,956,196

The full Boston Scientific compensation record

free company brief

This page is one person within Boston Scientific's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Boston Scientific proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Boston Scientific's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Edward Mackey's compensation dossier · One-time report. No refunds.